Andrea Natale, MD, executive medical director of the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, is now affiliated with Al-Sabah Arrhythmia Institute at St. Luke’s Hospital in New York City.
A prominent leader in the field of electrophysiology, Natale has pioneered and developed several treatments for atrial fibrillation, including a circumferential ultrasound vein-ablation system and catheter-based procedures such as percutaneous epicardial radiofrequency ablation. A prolific researcher, he has published more than 350 articles, received dozens of honors and awards and has contributed to numerous journals.
He is principal investigator of several key clinical trials, including CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial) and COMPARE (Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation Patients Undergoing Catheter Ablation).
He previously worked as section head for the department of cardiac pacing and electrophysiology and as medical director at the Cleveland Clinic’s Center for Atrial Fibrillation and as director of the electrophysiology laboratory at the Durham Veterans Affairs Medical Center in North Carolina.
He earned his MD from the University of Florence in Italy and completed fellowships in cardiology and cardiac electrophysiology at the University of Western Ontario in London, Canada, and the University of Wisconsin’s Sinai Samaritan Medical Center in Milwaukee.
Other staff additions at the Al-Sabah Arrhythmia Institute are:
- Conor D. Barrett, MD, as director of the institute;
- Stephan Danik, MD, MMSc, as director of the electrophysiology laboratory; and
- Robert K. Altman, MD, as a member of the medical staff.